Department of Medicine, Division of General Internal Medicine - Academic, University of Nebraska Medical Center, Omaha, NE, USA.
Department of Medicine, Veterans Affairs Nebraska Western Iowa Health Care System, Omaha, NE, USA.
J Gastrointest Surg. 2018 Aug;22(8):1376-1384. doi: 10.1007/s11605-018-3743-8. Epub 2018 Apr 5.
Severe chronic kidney disease (CKD) predicts adverse outcomes in patients undergoing pancreatectomy, but the impact of milder CKD is unknown. Additionally, some authors have suggested that, due to physiologic changes of aging, CKD is over-diagnosed in patients above age 65.
Patients undergoing pancreatectomy for malignancy from 2005 to 2014 were identified from the National Surgical Quality Improvement Program. Primary outcomes were all-cause mortality and major complication, defined as myocardial infarction, cardiac arrest, stroke, venous thromboembolism, respiratory failure, deep surgical site infection, pneumonia, acute kidney injury, coma > 24 h, or re-operation occurring within 30 days of surgery.
The mean age of 16,173 participants was 66 (range 18-90). Median preoperative creatinine was 0.80 mg/dL (0.10-11.0), and median preoperative eGFR was 86.36 mL/min/1.73m (2.98-182.2). Mortality and major complication occurred in 3 and 23% of patients, respectively. In adjusted analyses, CKD stages 2 (adjusted odds ratio (aOR) 1.24, 95% confidence interval (CI) 1.10-1.40), 3a (aOR 1.50, 95% CI 1.24-1.82), 3b (aOR 1.56, 95% CI 1.19-2.06), and 4 (aOR 2.17, 95% CI 1.25-3.76) were associated with increased major complication, and CKD stage 4 was associated with increased mortality (aOR 2.68, 95% CI 1.10-6.56). Age did not influence the relationship between CKD and either outcome.
CKD of any stage was associated with an increased risk of postoperative major complication, and severe CKD was associated with increased mortality among patients undergoing pancreatectomy for malignancy. These associations were not diminished in elderly patients. Our findings could inform preoperative counseling and decision-making.
严重的慢性肾脏疾病(CKD)可预测接受胰腺切除术的患者的不良结局,但轻度 CKD 的影响尚不清楚。此外,一些作者认为,由于年龄增长的生理变化,65 岁以上患者的 CKD 被过度诊断。
从国家手术质量改进计划中确定了 2005 年至 2014 年期间因恶性肿瘤接受胰腺切除术的患者。主要结局是全因死亡率和主要并发症,定义为心肌梗死、心脏骤停、中风、静脉血栓栓塞、呼吸衰竭、深部手术部位感染、肺炎、急性肾损伤、昏迷>24 小时或术后 30 天内再次手术。
16173 名参与者的平均年龄为 66 岁(范围 18-90 岁)。术前肌酐中位数为 0.80mg/dL(0.10-11.0),术前 eGFR 中位数为 86.36mL/min/1.73m(2.98-182.2)。分别有 3%和 23%的患者发生死亡和主要并发症。在调整后的分析中,CKD 2 期(调整后的优势比(aOR)1.24,95%置信区间(CI)1.10-1.40)、3a 期(aOR 1.50,95%CI 1.24-1.82)、3b 期(aOR 1.56,95%CI 1.19-2.06)和 4 期(aOR 2.17,95%CI 1.25-3.76)与主要并发症增加相关,而 CKD 4 期与死亡率增加相关(aOR 2.68,95%CI 1.10-6.56)。年龄并未影响 CKD 与任何结局之间的关系。
任何阶段的 CKD 都与接受恶性胰腺切除术的患者术后主要并发症风险增加相关,而严重的 CKD 与死亡率增加相关。在老年患者中,这些关联并未减弱。我们的研究结果可以为术前咨询和决策提供信息。